Vyant Bio enters into deal to sells its microBrain assets for $2.25M


Vyant has been exploring "strategic alternative transactions" with the help of LifeSci Capital.

Previous What founding multiple startups taught Fred Turner about entrepreneurship, leadership, health care
Next Nationwide Children's names new chief diversity and health equity officer